Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Sudeep Pharma Statistics

Total Valuation

Sudeep Pharma has a market cap or net worth of INR 83.82 billion. The enterprise value is 84.33 billion.

Market Cap	83.82B
Enterprise Value	84.33B

Important Dates

The last earnings date was Thursday, May 21, 2026.

Earnings Date	May 21, 2026
Ex-Dividend Date	n/a

Share Statistics

Sudeep Pharma has 112.95 million shares outstanding. The number of shares has increased by 2.80% in one year.

Current Share Class	112.95M
Shares Outstanding	112.95M
Shares Change (YoY)	+2.80%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	37.13%
Owned by Institutions (%)	14.39%
Float	25.44M

Valuation Ratios

The trailing PE ratio is 47.88 and the forward PE ratio is 43.40. Sudeep Pharma's PEG ratio is 3.65.

PE Ratio	47.88
Forward PE	43.40
PS Ratio	13.05
PB Ratio	9.33
P/TBV Ratio	10.37
P/FCF Ratio	n/a
P/OCF Ratio	120.52
PEG Ratio	3.65

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.00, with an EV/FCF ratio of -532.88.

EV / Earnings	48.78
EV / Sales	13.13
EV / EBITDA	38.00
EV / EBIT	40.72
EV / FCF	-532.88

Financial Position

The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.17.

Current Ratio	3.09
Quick Ratio	1.69
Debt / Equity	0.17
Debt / EBITDA	0.68
Debt / FCF	-9.51
Interest Coverage	27.23

Financial Efficiency

Return on equity (ROE) is 25.06% and return on invested capital (ROIC) is 20.61%.

Return on Equity (ROE)	25.06%
Return on Assets (ROA)	13.68%
Return on Invested Capital (ROIC)	20.61%
Return on Capital Employed (ROCE)	21.29%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	13.38M
Profits Per Employee	3.60M
Employee Count	740
Asset Turnover	0.68
Inventory Turnover	1.32

Taxes

In the past 12 months, Sudeep Pharma has paid 537.90 million in taxes.

Income Tax	537.90M
Effective Tax Rate	23.58%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	650.25
200-Day Moving Average	n/a
Relative Strength Index (RSI)	73.24
Average Volume (20 Days)	246,701

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sudeep Pharma had revenue of INR 6.42 billion and earned 1.73 billion in profits. Earnings per share was 15.50.

Revenue	6.42B
Gross Profit	4.15B
Operating Income	2.07B
Pretax Income	2.28B
Net Income	1.73B
EBITDA	2.22B
EBIT	2.07B
Earnings Per Share (EPS)	15.50

Balance Sheet

The company has 1.15 billion in cash and 1.50 billion in debt, with a net cash position of -357.77 million or -3.17 per share.

Cash & Cash Equivalents	1.15B
Total Debt	1.50B
Net Cash	-357.77M
Net Cash Per Share	-3.17
Equity (Book Value)	8.98B
Book Value Per Share	79.16
Working Capital	4.22B

Cash Flow

In the last 12 months, operating cash flow was 695.53 million and capital expenditures -853.78 million, giving a free cash flow of -158.25 million.

Operating Cash Flow	695.53M
Capital Expenditures	-853.78M
Depreciation & Amortization	148.09M
Net Borrowing	102.91M
Free Cash Flow	-158.25M
FCF Per Share	-1.40

Margins

Gross margin is 64.61%, with operating and profit margins of 32.24% and 26.92%.

Gross Margin	64.61%
Operating Margin	32.24%
Pretax Margin	35.51%
Profit Margin	26.92%
EBITDA Margin	34.55%
EBIT Margin	32.24%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 0.20%.

Dividend Per Share	1.50
Dividend Yield	0.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.80%
Shareholder Yield	-2.60%
Earnings Yield	2.06%
FCF Yield	-0.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5